CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages

Journal of Experimental Medicine

Volumn 212, Issue 7, 2015, Pages 1043-1059

  Kitamura, Takanori ^a   Qian, Bin Zhi ^a   Soong, Daniel ^a   Cassetta, Luca ^a   Noy, Roy ^b   Sugano, Gaël ^a   Kato, Yu ^b   Li, Jiufeng ^b   Pollard, Jeffrey W ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; CCL3 PROTEIN, MOUSE; CCR1 PROTEIN, MOUSE; CCR2 PROTEIN, MOUSE; CCR5 PROTEIN, MOUSE; CHEMOKINE RECEPTOR CCR5; PRIMER DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; DRUG TARGETING; GENE SILENCING; HUMAN; HUMAN CELL; LUNG METASTASIS; MACROPHAGE; METASTASIS ASSOCIATED MACROPHAGE; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ADOPTIVE TRANSFER; ANIMAL; BREAST TUMOR; C57BL MOUSE; CYTOLOGY; DEFICIENCY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; KNOCKOUT MOUSE; LUMINESCENCE; LUNG TUMOR; METABOLISM; METASTASIS; MICROARRAY ANALYSIS; PATHOPHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SECONDARY;

ADOPTIVE TRANSFER; ANIMALS; BREAST NEOPLASMS; CHEMOKINE CCL2; CHEMOKINE CCL3; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; LUMINESCENT MEASUREMENTS; LUNG NEOPLASMS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROARRAY ANALYSIS; NEOPLASM METASTASIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CCR1; RECEPTORS, CCR2; RECEPTORS, CCR5;

EID: 84934307169     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20141836     Document Type: Article

References (59)

1. Bernardini, G., G. Sciumè, D. Bosisio, S. Morrone, S. Sozzani, A. Santoni. 2008. CCL3 and CXCL12 regulate trafficking of mouse bone marrow NK cell subsets. Blood. 111:3626-3634. http://dx.doi.org/10.1182/ blood-2007-08-106203.
2. Bingle, L., N.J. Brown, C.E. Lewis. 2002. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J. Pathol. 196:254-265. http://dx.doi.org/10.1002/path.1027.
3. Bonapace, L., M.M. Coissieux, J. Wyckoff, K.D. Mertz, Z. Varga, T. Junt, M. Bentires-Alj. 2014. Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis. Nature. 515:130- 133. http://dx.doi.org/10.1038/nature13862.
4. Borowsky, A.D., R. Namba, L.J.T. Young, K.W. Hunter, J.G. Hodgson, C.G. Tepper, E.T. McGoldrick, W.J. Muller, R.D. Cardiff, J.P. Gregg. 2005. Syngeneic mouse mammary carcinoma cell lines: two closely related cell lines with divergent metastatic behavior. Clin. Exp. Metastasis. 22:47-59. http://dx.doi.org/10.1007/s10585-005-2908-5.
5. Cain, D.W., P.B. Snowden, G.D. Sempowski, G. Kelsoe. 2011. Inflammation triggers emergency granulopoiesis through a density-dependent feedback mechanism. PLoS ONE. 6:e19957. http://dx.doi.org/10.1371/ journal.pone.0019957.
6. Cassetta, L., A. Kajaste-Rudnitski, T. Coradin, E. Saba, G. Della Chiara, M. Barbagallo, F. Graziano, M. Alfano, E. Cassol, E. Vicenzi, G. Poli. 2013. M1 polarization of human monocyte-derived macrophages restricts pre and postintegration steps of HIV-1 replication. AIDS. 27: 1847-1856. http://dx.doi.org/10.1097/QAD.0b013e328361d059.
7. Chen, Q., X.H. Zhang, J. Massagué. 2011. Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs. Cancer Cell. 20:538-549. http://dx.doi.org/10.1016/ j.ccr.2011.08.025.
8. Dairaghi, D.J., P. Zhang, Y. Wang, L.C. Seitz, D.A. Johnson, S. Miao, L.S. Ertl, Y. Zeng, J.P. Powers, A.M. Pennell, et al. 2011. Pharmacokinetic and pharmacodynamic evaluation of the novel CCR1 antagonist CCX354 in healthy human subjects: implications for selection of clinical dose. Clin. Pharmacol. Ther. 89:726-734. http://dx.doi.org/10.1038/clpt.2011.33.
9. Dairaghi, D.J., B.O. Oyajobi, A. Gupta, B. McCluskey, S. Miao, J.P. Powers, L.C. Seitz, Y. Wang, Y. Zeng, P. Zhang, et al. 2012. CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease. Blood. 120:1449-1457. http://dx.doi.org/10.1182/ blood-2011-10-384784.
10. Davies, L.C., S.J. Jenkins, J.E. Allen, P.R. Taylor. 2013. Tissue-resident macrophages. Nat. Immunol. 14:986-995. http://dx.doi.org/10.1038/ ni.2705.
11. Eis, V., B. Luckow, V. Vielhauer, J.T. Siveke, Y. Linde, S. Segerer, G. Perez De Lema, C.D. Cohen, M. Kretzler, M. Mack, et al. 2004. Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction. J. Am. Soc. Nephrol. 15:337-347. http://dx.doi.org/10.1097/01 .ASN.0000111246.87175.32.
12. Ewens, A., E. Mihich, M.J. Ehrke. 2005. Distant metastasis from subcutaneously grown E0771 medullary breast adenocarcinoma. Anticancer Res. 25(6B):3905-3915.
13. Farmer, P., H. Bonnefoi, V. Becette, M. Tubiana-Hulin, P. Fumoleau, D. Larsimont, G. Macgrogan, J. Bergh, D. Cameron, D. Goldstein, et al. 2005. Identification of molecular apocrine breast tumours by microarray analysis. Oncogene. 24:4660-4671. http://dx.doi.org/10.1038/sj.onc .1208561.
14. Finak, G., N. Bertos, F. Pepin, S. Sadekova, M. Souleimanova, H. Zhao, H. Chen, G. Omeroglu, S. Meterissian, A. Omeroglu, et al. 2008. Stromal gene expression predicts clinical outcome in breast cancer. Nat. Med. 14:518-527. http://dx.doi.org/10.1038/nm1764.
15. Fischer, F.R., Y. Luo, M. Luo, L. Santambrogio, M.E. Dorf. 2001. RANTES-induced chemokine cascade in dendritic cells. J. Immunol. 167:1637-1643. http://dx.doi.org/10.4049/jimmunol.167.3.1637.
16. Franklin, R.A., W. Liao, A. Sarkar, M.V. Kim, M.R. Bivona, K. Liu, E.G. Pamer, M.O. Li. 2014. The cellular and molecular origin of tumorassociated macrophages. Science. 344:921-925. http://dx.doi.org/10.1126/ science.1252510.
17. Hanahan, D., L.M. Coussens. 2012. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 21:309-322. http://dx.doi.org/10.1016/j.ccr.2012.02.022.
18. Huffnagle, G.B., R.M. Strieter, L.K. McNeil, R.A. McDonald, M.D. Burdick, S.L. Kunkel, G.B. Toews. 1997. Macrophage inflammatory protein-1α (MIP-1α) is required for the efferent phase of pulmonary cell-mediated immunity to a Cryptococcus neoformans infection. J. Immunol. 159:318-327.
19. Hussell, T., T.J. Bell. 2014. Alveolar macrophages: plasticity in a tissuespecific context. Nat. Rev. Immunol. 14:81-93. http://dx.doi.org/10 .1038/nri3600.
20. Iida, N., Y. Nakamoto, T. Baba, K. Kakinoki, Y.Y. Li, Y. Wu, K. Matsushima, S. Kaneko, N. Mukaida. 2008. Tumor cell apoptosis induces tumor-specific immunity in a CC chemokine receptor 1- and 5-dependent manner in mice. J. Leukoc. Biol. 84:1001-1010. http://dx .doi.org/10.1189/jlb.1107791.
21. Jemal, A., F. Bray, M.M. Center, J. Ferlay, E. Ward, D. Forman. 2011. Global cancer statistics. CA Cancer J. Clin. 61:69-90. http://dx.doi.org/ 10.3322/caac.20107.
22. Joyce, J.A., J.W. Pollard. 2009. Microenvironmental regulation of metastasis. Nat. Rev. Cancer. 9:239-252. http://dx.doi.org/10.1038/ nrc2618.
23. Kaufmann, A., R. Salentin, D. Gemsa, H. Sprenger. 2001. Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1 ? during differentiation of human monocytes to macrophages. J. Leukoc. Biol. 69:248-252.
24. Kitamura, T., T. Fujishita, P. Loetscher, L. Revesz, H. Hashida, S. Kizaka- Kondoh, M. Aoki, M.M. Taketo. 2010. Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model. Proc. Natl. Acad. Sci. USA. 107:13063-13068. http://dx.doi.org/10 .1073/pnas.1002372107.
25. Knowles, H.J., A.L. Harris. 2007. Macrophages and the hypoxic tumour microenvironment. Front. Biosci. 12:4298-4314. http://dx.doi .org/10.2741/2389.
26. Leek, R.D., C.E. Lewis, R. Whitehouse, M. Greenall, J. Clarke, A.L. Harris. 1996. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 56:4625-4629.
27. Li, J., K. Chen, L. Zhu, J.W. Pollard. 2006. Conditional deletion of the colony stimulating factor-1 receptor (c-fms proto-oncogene) in mice. Genesis. 44:328-335. http://dx.doi.org/10.1002/dvg.20219.
28. Lin, E.Y., A.V. Nguyen, R.G. Russell, J.W. Pollard. 2001. Colonystimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med. 193:727-740. http://dx.doi.org/10.1084/ jem.193.6.727.
29. Lin, E.Y., J.G. Jones, P. Li, L. Zhu, K.D. Whitney, W.J. Muller, J.W. Pollard. 2003. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am. J. Pathol. 163:2113-2126. http://dx.doi.org/10.1016/ S0002-9440(10)63568-7.
30. Lloyd, A.R., J.J. Oppenheim, D.J. Kelvin, D.D. Taub. 1996. Chemokines regulate T cell adherence to recombinant adhesion molecules and extracellular matrix proteins. J. Immunol. 156:932-938.
31. Lu, X., Y. Kang. 2009. Chemokine (C-C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone. J. Biol. Chem. 284:29087-29096. http://dx.doi.org/ 10.1074/jbc.M109.035899.
32. Luo, Y., F.R. Fischer, W.W. Hancock, M.E. Dorf. 2000. Macrophage inflammatory protein-2 and KC induce chemokine production by mouse astrocytes. J. Immunol. 165:4015-4023. http://dx.doi.org/ 10.4049/jimmunol.165.7.4015.
33. Matsushima, K., C.G. Larsen, G.C. DuBois, J.J. Oppenheim. 1989. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J. Exp. Med. 169:1485-1490. http://dx.doi.org/10.1084/jem.169.4.1485.
34. Minn, A.J., G.P. Gupta, P.M. Siegel, P.D. Bos, W. Shu, D.D. Giri, A. Viale, A.B. Olshen, W.L. Gerald, J. Massagué. 2005. Genes that mediate breast cancer metastasis to lung. Nature. 436:518-524. http://dx.doi .org/10.1038/nature03799.
35. Nakasone, Y., M. Fujimoto, T. Matsushita, Y. Hamaguchi, D.L. Huu, M. Yanaba, S. Sato, K. Takehara, M. Hasegawa. 2012. Host-derived MCP-1 and MIP-1a regulate protective anti-tumor immunity to localized and metastatic B16 melanoma. Am. J. Pathol. 180:365-374. http:// dx.doi.org/10.1016/j.ajpath.2011.09.005.
36. Neote, K., D. DiGregorio, J.Y. Mak, R. Horuk, T.J. Schall. 1993. Molecular cloning, functional expression, signaling characteristics of a C-C chemokine receptor. Cell. 72:415-425. http://dx.doi.org/ 10.1016/0092-8674(93)90118-A.
37. Oba, Y., J.W. Lee, L.A. Ehrlich, H.Y. Chung, D.F. Jelinek, N.S. Callander, R. Horuk, S.J. Choi, G.D. Roodman. 2005. MIP-1α utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells. Exp. Hematol. 33:272-278. http://dx.doi.org/10.1016/j.exphem.2004.11.015.
38. Ojalvo, L.S., W. King, D. Cox, J.W. Pollard. 2009. High-density gene expression analysis of tumor-associated macrophages from mouse mammary tumors. Am. J. Pathol. 174:1048-1064. http://dx.doi.org/10 .2353/ajpath.2009.080676.
39. Pollard, J.W. 2009. Trophic macrophages in development and disease. Nat. Rev. Immunol. 9:259-270. http://dx.doi.org/10.1038/nri2528.
40. Prest, S.J., R.C. Rees, C. Murdoch, J.F. Marshall, P.A. Cooper, M. Bibby, G. Li, S.A. Ali. 1999. Chemokines induce the cellular migration of MCF-7 human breast carcinoma cells: subpopulations of tumour cells display positive and negative chemotaxis and differential in vivo growth potentials. Clin. Exp. Metastasis. 17:389-396. http://dx.doi.org/ 10.1023/A:1006657109866.
41. Qian, B.-Z., J.W. Pollard. 2010. Macrophage diversity enhances tumor progression and metastasis. Cell. 141:39-51. http://dx.doi.org/10.1016/ j.cell.2010.03.014.
42. Qian, B., Y. Deng, J.H. Im, R.J. Muschel, Y. Zou, J. Li, R.A. Lang, J.W. Pollard. 2009. A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth. PLoS ONE. 4:e6562. http://dx.doi.org/10.1371/journal.pone.0006562.
43. Qian, B.-Z., J. Li, H. Zhang, T. Kitamura, J. Zhang, L.R. Campion, E.A. Kaiser, L.A. Snyder, J.W. Pollard. 2011. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature. 475:222- 225. http://dx.doi.org/10.1038/nature10138.
44. Ramos, C.D.L., C. Canetti, J.T. Souto, J.S. Silva, C.M. Hogaboam, S.H. Ferreira, F.Q. Cunha. 2005. MIP-1α[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-α and LTB4. J. Leukoc. Biol. 78:167-177. http://dx.doi.org/10.1189/jlb.0404237.
45. Roca, H., Z.S. Varsos, S. Sud, M.J. Craig, C. Ying, K.J. Pienta. 2009. CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization. J. Biol. Chem. 284:34342-34354. http://dx.doi.org/10.1074/ jbc.M109.042671.
46. Rodero, M.P., C. Auvynet, L. Poupel, B. Combadière, C. Combadière. 2013. Control of both myeloid cell infiltration and angiogenesis by CCR1 promotes liver cancer metastasis development in mice. Neoplasia. 15:641-648. http://dx.doi.org/10.1593/neo.121866.
47. Sandhu, S.K., K. Papadopoulos, P.C. Fong, A. Patnaik, C. Messiou, D. Olmos, G. Wang, B.J. Tromp, T.A. Puchalski, F. Balkwill, et al. 2013. A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors. Cancer Chemother. Pharmacol. 71:1041-1050. http://dx.doi.org/10.1007/s00280-013-2099-8.
48. Schall, T.J., A.E.I. Proudfoot. 2011. Overcoming hurdles in developing successful drugs targeting chemokine receptors. Nat. Rev. Immunol. 11:355-363. http://dx.doi.org/10.1038/nri2972.
49. Schaller, M.A., L.E. Kallal, N.W. Lukacs. 2008. A key role for CC chemokine receptor 1 in T-cell-mediated respiratory inflammation. Am. J. Pathol. 172:386-394. http://dx.doi.org/10.2353/ajpath.2008.070537.
50. Serbina, N.V., T. Jia, T.M. Hohl, E.G. Pamer. 2008. Monocyte-mediated defense against microbial pathogens. Annu. Rev. Immunol. 26:421-452. http://dx.doi.org/10.1146/annurev.immunol.26.021607.090326.
51. Suehiro, Y., K. Muta, T. Umemura, Y. Abe, J. Nishimura, H. Nawata. 1999. Macrophage inflammatory protein 1α enhances in a different manner adhesion of hematopoietic progenitor cells from bone marrow, cord blood, mobilized peripheral blood. Exp. Hematol. 27:1637- 1645. http://dx.doi.org/10.1016/S0301-472X(99)00103-4.
52. Tak, P.P., A. Balanescu, V. Tseluyko, S. Bojin, E. Drescher, D. Dairaghi, S. Miao, V. Marchesin, J. Jaen, T.J. Schall, P. Bekker. 2013. Chemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: CARAT-2, a randomised, placebo controlled clinical trial. Ann. Rheum. Dis. 72:337-344. http://dx.doi.org/10.1136/annrheumdis-2011-201605.
53. Tanaka, T., M. Terada, K. Ariyoshi, K. Morimoto. 2010. Monocyte chemoattractant protein-1/CC chemokine ligand 2 enhances apoptotic cell removal by macrophages through Rac1 activation. Biochem. Biophys. Res. Commun. 399:677-682. http://dx.doi.org/10.1016/j.bbrc.2010.07.141.
54. Tushinski, R.J., I.T. Oliver, L.J. Guilbert, P.W. Tynan, J.R. Warner, E.R. Stanley. 1982. Survival of mononuclear phagocytes depends on a lineagespecific growth factor that the differentiated cells selectively destroy. Cell. 28:71-81. http://dx.doi.org/10.1016/0092-8674(82)90376-2.
55. Wang, M.J., K.C.G. Jeng, P.C. Shih. 2000. Differential expression and regulation of macrophage inflammatory protein (MIP)-1α and MIP-2 genes by alveolar and peritoneal macrophages in LPS-hyporesponsive C3H/HeJ mice. Cell. Immunol. 204:88-95. http://dx.doi.org/10.1006/ cimm.2000.1697.
56. Weber, C., K.S.C. Weber, C. Klier, S. Gu, R. Wank, R. Horuk, P.J. Nelson. 2001. Specialized roles of the chemokine receptors CCR1 and CCR5 in the recruitment of monocytes and T(H)1-like/CD45RO(+) T cells. Blood. 97:1144-1146. http://dx.doi.org/10.1182/blood.V97.4.1144.
57. Wu, Y., Y.-Y. Li, K. Matsushima, T. Baba, N. Mukaida. 2008. CCL3- CCR5 axis regulates intratumoral accumulation of leukocytes and fibroblasts and promotes angiogenesis in murine lung metastasis process. J. Immunol. 181:6384-6393. http://dx.doi.org/10.4049/jimmunol.181 .9.6384.
58. Youngs, S.J., S.A. Ali, D.D. Taub, R.C. Rees. 1997. Chemokines induce migrational responses in human breast carcinoma cell lines. Int. J. Cancer. 71:257-266. http://dx.doi.org/10.1002/(SICI)1097- 0215(19970410)71:2257::AID-IJC223.0.CO;2-D.
59. Zhu, X., M. Fujita, L.A. Snyder, H. Okada. 2011. Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy. J. Neurooncol. 104:83-92. http://dx.doi.org/10.1007/s11060-010-0473-5.